Search results
Novavax stock doubles after Sanofi deal marks 'new chapter' for company
Yahoo Finance via AOL· 16 hours agoWhile Novavax's vaccine did finally reach the market in mid-2022 targeting the booster...
Novavax strikes $1.2 billion deal with Sanofi in major turnaround
Axios· 18 hours agoDriving the news: Novavax will receive an upfront payment of $500 million and up to $700 million in...
Novavax shares soar on license deal with Sanofi at lofty valuation
Reuters· 16 hours ago, opens new tab for its COVID-19 vaccine in exchange for a stake that valued the U.S. biotech firm...
Press Release: Sanofi and Novavax announce co-exclusive licensing agreement to co-commercialize...
Benzinga· 1 day agoSanofi and Novavax announce co-exclusive licensing agreement to co-commercialize COVID-19 vaccine and develop novel ...
Novavax signs multibillion-dollar deal with Sanofi to commercialize Covid vaccine, develop...
CNBC· 1 day agoThe licensing agreement will allow Novavax to lift its "going concern" warning, which it first...
Why Novavax Stock More Than Doubled Today
Motley Fool via Yahoo Finance· 19 hours agoAs part of the deal, Sanofi is also purchasing an equity stake in Novavax worth $500 million. Novavax believes that this agreement...company could ever...
Shah Capital urges Novavax shareholders to vote against three directors
Reuters via Yahoo News· 5 days ago(Reuters) -Hedge fund Shah Capital on Monday urged Novavax shareholders to vote against the...
Novavax (NVAX) Reports Q1 Loss, Lags Revenue Estimates
Zacks via Yahoo Finance· 1 day agoNovavax (NVAX) delivered earnings and revenue surprises of -0.96% and 7.30%, respectively, for the...
Novavax (NVAX) Increases Despite Market Slip: Here's What You Need to Know
Zacks· 2 weeks agoFree Report) closed at $4.33, marking a +0.93% move from the previous day. Shares of the vaccine maker have depreciated by 7.74% over the course of the past month, underperforming ...
NVAX Stock Alert: Novavax Just Hit a New 52-Week High
InvestorPlace· 19 hours agoNovavax (NASDAQ:NVAX) stock investors are celebrating on Friday as the vaccine company’s shares hit...